FANCI promotes esophageal squamous cell carcinoma progression and cell cycle regulation and interacts with FANCD2
Beibei Hua, Tao Ye, Huijie Huang, Weiwei Wang, Xuezhi Chang, Ruozheng Wang · 2026
Read FANCI promotes esophageal squamous cell carcinoma progression and cell cycle regulation and interacts with FANCD2 by Beibei Hua, Tao Ye, Huijie Huang, Weiwei Wang, Xuezhi Chang, Ruozheng Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13546521.txt.
Description
Beibei Hua and colleagues examined in 2026 the role of FANCI, a protein from the Fanconi anemia DNA repair pathway, in esophageal squamous cell carcinoma. Using several public cancer datasets plus single-cell data, they found FANCI switched on at high levels in tumors, where it separated cancer tissue from normal tissue with high accuracy. High levels also tracked with shorter survival.
In cell experiments, raising FANCI pushed cancer cells to grow, spread, and resist death, while silencing it slowed tumors in mice and stalled the cell cycle. The protein was found physically bound to its pathway partner FANCD2 inside the nucleus. The authors propose FANCI as a possible marker for diagnosis and prognosis, and as a candidate drug target.
Catalog record
| CREATOR | Beibei Hua, Tao Ye, Huijie Huang, Weiwei Wang, Xuezhi Chang, Ruozheng Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48360 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |